TTK HEALTHCARE
Back to Cashflow Statement
|
TTK HEALTHCARE Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-18 Cr | ₹-22 Cr | ₹-12 Cr | ₹-10 Cr | ₹-17 Cr |
What is the latest Cash Flow from Financing Activities ratio of TTK HEALTHCARE ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2025 | ₹-18 Cr |
Mar2024 | ₹-22 Cr |
Mar2023 | ₹-12 Cr |
Mar2022 | ₹-10 Cr |
Mar2021 | ₹-17 Cr |
How is Cash Flow from Financing Activities of TTK HEALTHCARE Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2025 | ₹-18 Cr | Negative | |
Mar2024 | ₹-22 Cr | Negative | |
Mar2023 | ₹-12 Cr | Negative | |
Mar2022 | ₹-10 Cr | Negative | |
Mar2021 | ₹-17 Cr | - |
Compare Cash Flow from Financing Activities of peers of TTK HEALTHCARE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TTK HEALTHCARE | ₹1,859.2 Cr | -2.6% | 2.9% | -6.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,872.0 Cr | 0.7% | 2.8% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,609.0 Cr | -0.8% | 3.7% | 48.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,277.0 Cr | 3.4% | 11.2% | 17.9% | Stock Analytics | |
CIPLA | ₹119,184.0 Cr | -0.2% | -0.1% | -1.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,116.0 Cr | 0.6% | -5.2% | -4.9% | Stock Analytics |
TTK HEALTHCARE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TTK HEALTHCARE | -2.6% |
2.9% |
-6.6% |
SENSEX | -0.1% |
1% |
1.8% |
You may also like the below Video Courses